Comcast spent tons on lobbying and image-burnishing philanthropy while its CEO golfed with President Obama, yet the telecom giant was blocked from carrying out its anti-competitive $45 billion acquisition of Time Warner Cable. It’s encouraging to see that large corporations do not always get their way in Washington.
Another good sign came a few days later, when two of the largest semiconductor machinery producers, Applied Materials of the United States and Tokyo Electron of Japan, called off their planned merger after the U.S. Justice Department said the deal would restrict competition. Another problem was that Applied Materials planned to reincorporate in Japan after the acquisition to dodge U.S. taxes.
It would be nice to think that these aborted mergers are signs of an antitrust revival in the United States, but there is more evidence pointing in the opposite direction. Large, competition-inhibiting mergers are being announced all the time.
For example, Teva Pharmaceuticals recently made a $40 billion bid for its generic drug rival Mylan NV, seeking to trump a $28 billion offer Mylan had previously made for a third company, Perrigo. Berkshire Hathaway and Brazil’s 3G Capital, which took over Heinz in 2013, are seeking to merge the company with Kraft Foods. Earlier, Staples announced plans to acquire one of its few remaining competitors, Office Depot.
Last year, AT&T proposed to buy DirecTV for $48 billion, Halliburton offered $34 billion for Baker Hughes, and Reynolds American announced plans to buy competing tobacco company Lorillard for $27 billion. The list could go on.
It remains to be seen whether the Justice Department and the Federal Trade Commission will block these deals. Chances are that most of them will be allowed to proceed intact or with only limited concessions. The Wall Street Journal reported in March that the FTC, facing pressure from Republicans in Congress, was revising its procedures in a way that might make it easier for deals such as Sysco’s proposed purchase of US Foods, which the agency had challenged, to go through.
Ironically, while U.S. antitrust policy may be weakening, China is beefing up its enforcement. It February, U.S. telecom and chip company Qualcomm was fined the equivalent of $975 million for violating the Chinese anti-monopoly law.
The sad truth is that oligopoly is increasingly the norm in the U.S. economy, and consumers feel the consequences. The low rate of overall inflation has dampened the impact, but the signs are there. As Andrew Ross Sorkin of the New York Times pointed out, the decline of competition in the airline industry through deals such as American’s purchase of US Airways has kept air fares high despite the savings the carriers are enjoying from plummeting fuel costs. The proposed acquisition of Orbitz by Expedia would not help things.
To reverse the troubling trend, what happened with Comcast needs to become the norm rather than the exception.
Generic drugmakers are supposed to be the heroes of the pharmaceutical business, injecting a dose of competition in what is otherwise a highly concentrated industry and thus putting restraints on the price-gouging tendencies of the brand-name producers.
The early episodes of the new Ken Burns documentary on the Roosevelts showing on PBS highlight Teddy’s role as a trust-buster, even addressing the debate between those like TR who wanted to more strictly regulate the giant conglomerates and those who wanted to dismantle them.
It is now a full century since the Progressive Era ended some of the worst abuses of concentrated economic power. This year is the 100th anniversary of the Clayton Act and the Federal Trade Commission Act. It is 103 years since the dissolution of the Standard Oil trust, 108 years since the passage of the Pure Food and Drug Act.
Mainstream economics would have us believe that interest rates are determined by the “invisible hand” of the market, except on those occasions when the Federal Reserve or other central banks intervene to modulate borrowing costs. One of the benefits of the current scandal embroiling the British bank Barclays is that it reveals the flimsy and fishy nature of one of the key rate-setting mechanisms of the global financial system.
For the past 30 years, Forbes magazine has used its annual 



You must be logged in to post a comment.